In order to find out whether resedation occurredfollowing antagonism withjlumazenil of sedation for minor oral surgery, in a double-blind randomised cross-over study thirty healthy Hong Kong Chinese patients undergoing bilateral third molar surgery at two visits were sedated with midazolam. Following surgery they received either jlumazenil or placebo at one visit and the alternative at the other visit. Recovery was monitored by observation and objective tests. Following recovery they were monitored for resedationfor a total period of two hours from the injection of the reversal agent. Resedation, sufficient to prevent a patient from being discharged to be accompanied home with an escort, did not occur provided the patient responded to verbal command following sedation.
In conscious sedation with midazolam for minor oral surgery, the doses of midazolam used are small and usually no increments are needed. Without an antagonist the patient is able to be discharged with an escort in about 60 to 120 minutes following sedation. 1 It has been reported that flumazenil, a specific benzodiazepine antagonist, reverses conscious sedation with midazolam so that patients are street-fit significantly earlier. 2 Thus if a patient wishes to leave the surgery earlier after a short surgical procedure, then it is advantageous to the surgeon to facilitate this by the use of flumazenil. As resedation may be a problem with flumazenil because of its fast redistribution and short elmination half-life, 3 if it is to be used in this manner it is necessary to find out how safe it is to discharge a patient following reversal of the sedative.
Therefore with the approval of the Ethical Committee of the Dental Faculty, a double-blind cross-over study was performed to find out whether resedation occurred following reversal with flumazenil (Anexate) of midazolam sedation carried out for oral surgery.
MATERIAL AND METHODS Thirty patients of either sex, between the ages of 15 and 29 years, scheduled to undergo surgical removal of bilateral impacted third molars at two visits, were included in the study on a voluntary basis. Only those patients of ASA grade 1, who were currently not taking any drugs other than antibiotics and who could bring a responsible person to accompany them home were admitted to the study. Informed consent was obtained.
Following grading,2 objective tests, namely p-deletion test, walking in a straight line, pivoting around a point and modified Romberg's test 2 were performed. Respiratory and cardiovascular monitoring was commenced, as in the previous study.2 Midazolam was administered intermittently, initially 2 mg and then at the rate of 1 mg/min to a clinical endpoint characterised by drooping of eyelids. Randomly, on one side, third molar surgery was carried out by the same surgeon in a standardised manner following the injection of a local anaesthetic (2% lignocaine with 1 :80,000 adrenaline). At the end of the surgical procedure following grading and completion of a p-depletion test the patient was randomly given 5 ml of either flumazenil 0.1 mg/ml or normal saline during a period of one minute. The reversal agents were packeted and coded by the drug company, thus making it a double-blind study.
Recovery was assessed by the surgeon's evaluation of the sedative effect and by objective tests. A patient was assessed as fit for discharge with an escort when he was able to perform all the objective tests. In order to find out whether resedation occurred, from the time they were assessed fit for discharge, surgeon's gradings and objective evaluations were repeated every fifteen minutes for a total period of two hours following the injection of the reversal agent. At the end of the two hours from the injection of the reversal agent, if patients were assessed fit for discharge following the above tests, then they were sent home with an escort with advice to rest at home. At the second visit the same dose of midazolam was given as at the first visit, surgery was done on the opposite side, the alternative reversal agent was used and the observations and recordings were carried out as before.
RESULTS
Of those included in the study, thirteen were males and seventeen were females. The average age was 22 (SD 4) years and the average weight was 55.2 (SD 10) kg. The average dose of midazolam needed for sedation was 6.2 (SD 1) mg and the range was 4 to 10 mg. The two groups were comparable with regard to the amount oflocal anaesthesia given, the duration of surgery and the average time and range from the end of injection of midazolam to the beginning of injection of the reversal agent (Table  1 ) .
At the preoperative evaluation, all were evaluated to be awake and not tense. At optimum sedation, all except one patient were assessed to be very drowsy at both visits.
A significant majority were assessed to have recovered quicker following flumazenil than following placebo both by subjective and objective evaluations ( Table 2 ). In 73.3% of patients recovery occurred within fifteen minutes of injecting flumazenil. 70% of the patients recovered 60 minutes earlier and 83.8% recovered 30 minutes earlier than placebo. All except one patient successfully completed the tests up to two hours from the end of injection of the reversal agent, after they were assessed fit for discharge.
A 66 kg male had midazolam 7 mg for sedation at the first visit and was assessed to have recovered following the injection of the reversal agent by subjective evaluation after fifteen minutes and by objective evaluation after 60 minutes. He successfully completed all the tests in the remaining period up to two hours. At the second visit he was given the same dose of midazolam. The patient was found not to respond to verbal command but respond only to deep stimuli. At the end of surgery, which lasted sixteen minutes, he was very drowsy and could delete only 4 p's in the p-deletion test. However following the injection of the reversal agent which was carried out after 22 minutes of sedation he was assessed to be awake and not tense and deleted 31 p's in the p-deletion test and successfully completed the balance tests. Fifteen minutes later, the patient could not do the modified Romberg'S test. He was assessed to be drowsy at the end of 30 minutes. At 75 minutes he could perform the modified Romberg'S test once again and at 90 minutes he was assessed to be awake and not tense, after which he successfully completed the tests till the end of the two-hour period. He performed all the other objective tests successfully throughout the test period.
DISCUSSION
This study confirms the findings in our previous study2 of the efficacy of flumazenil in reversing conscious sedation produced with midazolam.
The problem of resedation occurring after flumazenil reversal of midazolam sedation lies in its rapid elimination from plasma due to a short half-life of 40-58 minutes 3 compared with a longer half-life of 1.5-3 hours of midazolam. 4 When the effect of flumazenil declines, because it is a competitive antagonist at benzodiazepine receptors and does not affect the pharmacokinetics or metabolism of midazolam, its falling plasma levels allows its redisplacement from the binding sites by midazolam persisting in the circulation and the patient returns to the same state of sedation which would have been present had flumazenil not been given. 5 Apart from the pharmacokinetics of the two drugs, the factors which influence the possibility of re sedation include the relative doses of midazolam I and flumazenil and their relative times of administration.
In conscious sedation the dose of midazolam used is small, and mostly single doses given intermittently to a specific end-point without any increments are sufficient for the procedures. Even without an antagonist patients recover sufficiently to be sent home with an escort after 60 to 120 minutes. This study reveals that flumazenil facilitates recovery and patients could be discharged significantly earlier as resedation sufficient to affect the discharge of a patient to go home with an escort does not occur following reversal of conscious sedation with midazolam.
The patient who became oversedated when the same dose of midazolam was given at the second visit probably had a higher level of midazolam in his circulation than other patients. The flumazenil given would have been just sufficient to wake him up and enable him to perform the objective tests. Falling plasma levels due to recirculation may have resulted in his inability to perform the modified Romberg's test, which is the more difficult of the objective tests. Probably it indicates the insufficiency of the dose of flumazenil used in this patient and the danger of oversedating a patient.
Though we used difficult balance tests to assess recovery, normally a patient is discharged following sedation to be accompanied home with an escort to rest at home, when the patient is able to respond to command rationally, has normal respiratory and cardiovascular parameters for him, is able to walk steadily and has no surgical problems necessitating him to be hospitalised. Thus even if the above patient was discharged with an escort to go home and rest, probably nothing would have happened to the patient as he satisfied the above conditions. Yet even the degree of re sedation that occurred could have been avoided if the sedation had been titrated to avoid oversedation.
In minor oral surgery the required sedation period may be short as in this study. Here even after a period of ten minutes of sedation, following flumazenil the patient recovered significantly earlier than following placebo and no clinically detectable resedation, to prevent the patient from being discharged, was seen.
Titrating of a dose of flumazenil adequate to antagonise a dose ofmidazolam used for conscious sedation appears to be difficult. 2 In our previous study,2 2 ml or 0.2 mg of flumazenil adequately reversed sedation in only 32% of the patients. Thus it may be better to use a standard dose of 5 ml or O. 5 mg to reverse the sedation produced by midazolam in conscious sedation, as used in this study effectively. Unlike in our previous study,2 sideeffects such as palpitations and hyperventilation were not observed. This may have been prevented by slowing the injection of flumazenil to a period of one minute compared with rapid injection of 2 ml or 0.2 mg within 15 seconds in the previous study. 2 Though in the majority of cases the patients are fit to be discharged a few minutes after injection of flumazenil, some of them may take time to be adequately reversed. Thus it must never be assumed that a patient is fit for discharge following injection of flumazenil. It must be seen that the patient is able to walk steadily before being discharged.
Some studies have shown that following flumazenil, when its action declines, a patient returns to the same level of sedation which would have been present had flumazenil not been given. 5 Others have indicated that psychomotor tests do not return to normal for several hours after the injection of flumazeni1. 6 Thus at the time of discharge, the patient should be given the same postoperative instructions as a patient who is discharged following midazolam sedation without reversal with an antagonist, and advised to stay at home and rest on that day.
